World Neurosurgery, ISSN 1878-8750, 2016, Volume 93, pp. 489.e17 - 489.e20
Objective To present, to our knowledge, the first case of a single bilateral extradural hematoma due to superior sagittal sinus detachment that was treated...
Neurosurgery | Extradural | Bilateral | Detachment | Sagittal | Sinus | Hematoma | SURGERY | BILATERAL EPIDURAL HEMATOMA | CLINICAL NEUROLOGY | Neuroimaging - methods | Hematoma, Epidural, Cranial - drug therapy | Anticoagulants - administration & dosage | Humans | Anticonvulsants - administration & dosage | Brain Injuries - complications | Male | Treatment Outcome | Superior Sagittal Sinus - drug effects | Parietal Lobe - injuries | Drug Therapy, Combination - methods | Mannitol - administration & dosage | Piracetam - analogs & derivatives | Adult | Piracetam - administration & dosage | Heparin, Low-Molecular-Weight - administration & dosage | Superior Sagittal Sinus - injuries | Neuroprotective Agents - administration & dosage | Hematoma, Epidural, Cranial - etiology | Hospitals
Neurosurgery | Extradural | Bilateral | Detachment | Sagittal | Sinus | Hematoma | SURGERY | BILATERAL EPIDURAL HEMATOMA | CLINICAL NEUROLOGY | Neuroimaging - methods | Hematoma, Epidural, Cranial - drug therapy | Anticoagulants - administration & dosage | Humans | Anticonvulsants - administration & dosage | Brain Injuries - complications | Male | Treatment Outcome | Superior Sagittal Sinus - drug effects | Parietal Lobe - injuries | Drug Therapy, Combination - methods | Mannitol - administration & dosage | Piracetam - analogs & derivatives | Adult | Piracetam - administration & dosage | Heparin, Low-Molecular-Weight - administration & dosage | Superior Sagittal Sinus - injuries | Neuroprotective Agents - administration & dosage | Hematoma, Epidural, Cranial - etiology | Hospitals
Journal Article
Neuroscience, ISSN 0306-4522, 2015, Volume 306, pp. 39 - 49
Graphical abstract
Neurology | cerebral venous sinus thrombosis | model | blood–brain barrier | photochemical reaction | edema | Model | Cerebral venous sinus thrombosis | Edema | Photochemical reaction | Blood-brain barrier | blood-brain barrier | BLOOD-FLOW | DISTURBANCE | NEUROSCIENCES | STROKE | SUPERIOR SAGITTAL SINUS | VEIN-THROMBOSIS | TISSUE-PLASMINOGEN-ACTIVATOR | MOUSE MODEL | BRAIN-BARRIER DISRUPTION | words: cerebral venous sinus thrombosis | EXPRESSION | OCCLUSION | Rats, Wistar | Neovascularization, Pathologic | Rats | Male | Sinus Thrombosis, Intracranial - physiopathology | Thrombin | Motor Activity | Sinus Thrombosis, Intracranial - chemically induced | Blood-Brain Barrier - metabolism | Photochemical Processes | Superior Sagittal Sinus - drug effects | Rotarod Performance Test | Animals | Superior Sagittal Sinus - pathology | Lasers, Semiconductor | Disease Models, Animal | Fluorescein Angiography | Sinus Thrombosis, Intracranial - pathology | Thrombosis | Blood clot
Neurology | cerebral venous sinus thrombosis | model | blood–brain barrier | photochemical reaction | edema | Model | Cerebral venous sinus thrombosis | Edema | Photochemical reaction | Blood-brain barrier | blood-brain barrier | BLOOD-FLOW | DISTURBANCE | NEUROSCIENCES | STROKE | SUPERIOR SAGITTAL SINUS | VEIN-THROMBOSIS | TISSUE-PLASMINOGEN-ACTIVATOR | MOUSE MODEL | BRAIN-BARRIER DISRUPTION | words: cerebral venous sinus thrombosis | EXPRESSION | OCCLUSION | Rats, Wistar | Neovascularization, Pathologic | Rats | Male | Sinus Thrombosis, Intracranial - physiopathology | Thrombin | Motor Activity | Sinus Thrombosis, Intracranial - chemically induced | Blood-Brain Barrier - metabolism | Photochemical Processes | Superior Sagittal Sinus - drug effects | Rotarod Performance Test | Animals | Superior Sagittal Sinus - pathology | Lasers, Semiconductor | Disease Models, Animal | Fluorescein Angiography | Sinus Thrombosis, Intracranial - pathology | Thrombosis | Blood clot
Journal Article
Neurobiology of Disease, ISSN 0969-9961, 2013, Volume 64, pp. 1 - 7
Abstract Familial hemiplegic migraine type 1 (FHM-1) is a monogenic subtype of migraine with aura caused by missense mutations in the CACNA1A gene, which...
Neurology | Familial hemiplegic migraine | CACNA1A | Aura | Migraine | Trigeminovascular | MIDDLE MENINGEAL ARTERY | GENE-RELATED PEPTIDE | CERVICAL-SPINAL-CORD | TRIGEMINAL NUCLEUS | NEUROSCIENCES | SPREADING DEPRESSION | RETICULAR-FORMATION | SUPERIOR SAGITTAL SINUS | TRANSMITTER RELEASE | CALCIUM-CHANNELS | ANIMAL-MODELS | Superior Sagittal Sinus - metabolism | Thalamic Nuclei - metabolism | Electric Stimulation | Neural Pathways - drug effects | Calcium Channels - metabolism | Trigeminal Caudal Nucleus - metabolism | Nociception - physiology | Serotonin 5-HT1 Receptor Agonists - pharmacology | Mutation, Missense | Piperidines - pharmacology | Tryptamines - pharmacology | Nociception - drug effects | Neurons - metabolism | Neurons - drug effects | Calcium Channels - genetics | Trigeminal Nuclei - metabolism | Thalamic Nuclei - drug effects | Mice, Inbred C57BL | Proto-Oncogene Proteins c-fos - metabolism | Mice, Transgenic | Trigeminal Caudal Nucleus - drug effects | Gene Knock-In Techniques | Superior Sagittal Sinus - drug effects | Animals | Cerebellar Ataxia - genetics | Migraine Disorders - genetics | Trigeminal Nuclei - drug effects | Neural Pathways - metabolism | Mice | Calcium channels | Genetic aspects | Genetic engineering
Neurology | Familial hemiplegic migraine | CACNA1A | Aura | Migraine | Trigeminovascular | MIDDLE MENINGEAL ARTERY | GENE-RELATED PEPTIDE | CERVICAL-SPINAL-CORD | TRIGEMINAL NUCLEUS | NEUROSCIENCES | SPREADING DEPRESSION | RETICULAR-FORMATION | SUPERIOR SAGITTAL SINUS | TRANSMITTER RELEASE | CALCIUM-CHANNELS | ANIMAL-MODELS | Superior Sagittal Sinus - metabolism | Thalamic Nuclei - metabolism | Electric Stimulation | Neural Pathways - drug effects | Calcium Channels - metabolism | Trigeminal Caudal Nucleus - metabolism | Nociception - physiology | Serotonin 5-HT1 Receptor Agonists - pharmacology | Mutation, Missense | Piperidines - pharmacology | Tryptamines - pharmacology | Nociception - drug effects | Neurons - metabolism | Neurons - drug effects | Calcium Channels - genetics | Trigeminal Nuclei - metabolism | Thalamic Nuclei - drug effects | Mice, Inbred C57BL | Proto-Oncogene Proteins c-fos - metabolism | Mice, Transgenic | Trigeminal Caudal Nucleus - drug effects | Gene Knock-In Techniques | Superior Sagittal Sinus - drug effects | Animals | Cerebellar Ataxia - genetics | Migraine Disorders - genetics | Trigeminal Nuclei - drug effects | Neural Pathways - metabolism | Mice | Calcium channels | Genetic aspects | Genetic engineering
Journal Article
Journal of Stroke and Cerebrovascular Diseases, ISSN 1052-3057, 2016, Volume 25, Issue 10, pp. e192 - e199
Case A 24-year-old woman presented with headache, nausea, and vomiting, and was found to have chronic superior sagittal sinus (SSS) thrombosis and multiple...
Neurology | Cardiovascular | pial arteriovenous fistula | sagittal sinus thrombosis | radiosurgery | embolization | Dural arteriovenous fistula | CAVERNOUS SINUS | MANAGEMENT | VENOUS HYPERTENSION | CLASSIFICATION | NEUROSCIENCES | DEFICIENCY | MALFORMATIONS | STEREOTACTIC RADIOSURGERY | PERIPHERAL VASCULAR DISEASE | PROGRESSION | Arteriovenous Fistula - diagnosis | Central Nervous System Vascular Malformations - complications | Humans | Middle Aged | Sagittal Sinus Thrombosis - etiology | Radiosurgery | Child, Preschool | Sagittal Sinus Thrombosis - diagnostic imaging | Venous Thrombosis - diagnostic imaging | Male | Embolization, Therapeutic | Cerebral Angiography - methods | Sagittal Sinus Thrombosis - therapy | Young Adult | Ligation | Time Factors | Adult | Female | Child | Arteriovenous Fistula - complications | Arteriovenous Fistula - therapy | Venous Thrombosis - therapy | Central Nervous System Vascular Malformations - diagnostic imaging | Endovascular Procedures | Pia Mater - blood supply | Treatment Outcome | Computed Tomography Angiography | Venous Thrombosis - etiology | Superior Sagittal Sinus - drug effects | Craniotomy | Aged | Central Nervous System Vascular Malformations - therapy | Thrombosis | Blood clot
Neurology | Cardiovascular | pial arteriovenous fistula | sagittal sinus thrombosis | radiosurgery | embolization | Dural arteriovenous fistula | CAVERNOUS SINUS | MANAGEMENT | VENOUS HYPERTENSION | CLASSIFICATION | NEUROSCIENCES | DEFICIENCY | MALFORMATIONS | STEREOTACTIC RADIOSURGERY | PERIPHERAL VASCULAR DISEASE | PROGRESSION | Arteriovenous Fistula - diagnosis | Central Nervous System Vascular Malformations - complications | Humans | Middle Aged | Sagittal Sinus Thrombosis - etiology | Radiosurgery | Child, Preschool | Sagittal Sinus Thrombosis - diagnostic imaging | Venous Thrombosis - diagnostic imaging | Male | Embolization, Therapeutic | Cerebral Angiography - methods | Sagittal Sinus Thrombosis - therapy | Young Adult | Ligation | Time Factors | Adult | Female | Child | Arteriovenous Fistula - complications | Arteriovenous Fistula - therapy | Venous Thrombosis - therapy | Central Nervous System Vascular Malformations - diagnostic imaging | Endovascular Procedures | Pia Mater - blood supply | Treatment Outcome | Computed Tomography Angiography | Venous Thrombosis - etiology | Superior Sagittal Sinus - drug effects | Craniotomy | Aged | Central Nervous System Vascular Malformations - therapy | Thrombosis | Blood clot
Journal Article
5.
Full Text
Histopathological effects of different therapy strategies in experimental sinus thrombosis
Neurological Sciences, ISSN 1590-1874, 8/2014, Volume 35, Issue 8, pp. 1281 - 1285
The optimal treatment for cerebral venous thrombosis is still under debate. The histological consequences of different treatments have not been systematically...
Animal models | Abciximab | rt-PA | Factor VIII | Histology | Neurosurgery | Neuroradiology | GFAP | Neurology | Medicine & Public Health | Heparin | Psychiatry | Cerebral venous thrombosis | TISSUE-PLASMINOGEN ACTIVATOR | RAT | NEUROSCIENCES | CLINICAL NEUROLOGY | VEIN | Recombinant Proteins - therapeutic use | Neurons - pathology | Factor VIII - analysis | Astrocytes - pathology | Chlorides - toxicity | Antibodies, Monoclonal - therapeutic use | Male | Tissue Plasminogen Activator - therapeutic use | Enoxaparin - therapeutic use | Immunoglobulin Fab Fragments - therapeutic use | Enoxaparin - administration & dosage | Reperfusion | Fibrinolytic Agents - therapeutic use | Injections, Subcutaneous | Superior Sagittal Sinus - pathology | Neurons - drug effects | Temporal Lobe - pathology | Disease Models, Animal | Collateral Circulation - drug effects | Astrocytes - drug effects | Ferric Compounds - toxicity | Antibodies, Monoclonal - pharmacology | Glial Fibrillary Acidic Protein - analysis | Magnetic Resonance Angiography | Rats | Tissue Plasminogen Activator - administration & dosage | Recombinant Proteins - pharmacology | Enoxaparin - pharmacology | Rats, Sprague-Dawley | Sinus Thrombosis, Intracranial - chemically induced | Immunoglobulin Fab Fragments - pharmacology | Recombinant Proteins - administration & dosage | Brain - drug effects | Superior Sagittal Sinus - drug effects | Fibrinolytic Agents - pharmacology | Immunoglobulin Fab Fragments - administration & dosage | Animals | Tissue Plasminogen Activator - pharmacology | Antibodies, Monoclonal - administration & dosage | Thrombolytic Therapy | Brain - pathology | Fibrinolytic Agents - administration & dosage | Sinus Thrombosis, Intracranial - drug therapy | Temporal Lobe - drug effects | Observer Variation | Sinus Thrombosis, Intracranial - pathology | Glycosaminoglycans | Blood coagulation factor VIII | Iron compounds | Analysis | Anticoagulants (Medicine) | Thrombolytic drugs | Intermediate filament proteins | Thrombosis | Blood clot
Animal models | Abciximab | rt-PA | Factor VIII | Histology | Neurosurgery | Neuroradiology | GFAP | Neurology | Medicine & Public Health | Heparin | Psychiatry | Cerebral venous thrombosis | TISSUE-PLASMINOGEN ACTIVATOR | RAT | NEUROSCIENCES | CLINICAL NEUROLOGY | VEIN | Recombinant Proteins - therapeutic use | Neurons - pathology | Factor VIII - analysis | Astrocytes - pathology | Chlorides - toxicity | Antibodies, Monoclonal - therapeutic use | Male | Tissue Plasminogen Activator - therapeutic use | Enoxaparin - therapeutic use | Immunoglobulin Fab Fragments - therapeutic use | Enoxaparin - administration & dosage | Reperfusion | Fibrinolytic Agents - therapeutic use | Injections, Subcutaneous | Superior Sagittal Sinus - pathology | Neurons - drug effects | Temporal Lobe - pathology | Disease Models, Animal | Collateral Circulation - drug effects | Astrocytes - drug effects | Ferric Compounds - toxicity | Antibodies, Monoclonal - pharmacology | Glial Fibrillary Acidic Protein - analysis | Magnetic Resonance Angiography | Rats | Tissue Plasminogen Activator - administration & dosage | Recombinant Proteins - pharmacology | Enoxaparin - pharmacology | Rats, Sprague-Dawley | Sinus Thrombosis, Intracranial - chemically induced | Immunoglobulin Fab Fragments - pharmacology | Recombinant Proteins - administration & dosage | Brain - drug effects | Superior Sagittal Sinus - drug effects | Fibrinolytic Agents - pharmacology | Immunoglobulin Fab Fragments - administration & dosage | Animals | Tissue Plasminogen Activator - pharmacology | Antibodies, Monoclonal - administration & dosage | Thrombolytic Therapy | Brain - pathology | Fibrinolytic Agents - administration & dosage | Sinus Thrombosis, Intracranial - drug therapy | Temporal Lobe - drug effects | Observer Variation | Sinus Thrombosis, Intracranial - pathology | Glycosaminoglycans | Blood coagulation factor VIII | Iron compounds | Analysis | Anticoagulants (Medicine) | Thrombolytic drugs | Intermediate filament proteins | Thrombosis | Blood clot
Journal Article
Journal of Psychopharmacology, ISSN 0269-8811, 3/2016, Volume 30, Issue 3, pp. 294 - 302
The objective of this study was to examine whether white-matter (WM) connectivity of patients with schizophrenia at early stage of treatment is related to...
Schizophrenia | paliperidone | white-matter connectivity | treatment response | neuroimaging | MEDICATION | PREDICTS TREATMENT RESPONSE | NEGATIVE SYMPTOMS | ABNORMALITIES | PSYCHIATRY | ANISOTROPY | NEUROSCIENCES | 1ST-EPISODE SCHIZOPHRENIA | ATYPICAL ANTIPSYCHOTICS | CLINICAL NEUROLOGY | PHARMACOLOGY & PHARMACY | DYSFUNCTION | EXTENDED-RELEASE | REMISSION | Humans | White Matter - drug effects | Corpus Callosum - drug effects | Male | Nerve Net - drug effects | Internal Capsule - drug effects | Paliperidone Palmitate - therapeutic use | Superior Sagittal Sinus - drug effects | Anisotropy | Delayed-Action Preparations - therapeutic use | Adult | Female | Schizophrenia - drug therapy | External Capsule - drug effects | Neuroimaging | Care and treatment | Usage
Schizophrenia | paliperidone | white-matter connectivity | treatment response | neuroimaging | MEDICATION | PREDICTS TREATMENT RESPONSE | NEGATIVE SYMPTOMS | ABNORMALITIES | PSYCHIATRY | ANISOTROPY | NEUROSCIENCES | 1ST-EPISODE SCHIZOPHRENIA | ATYPICAL ANTIPSYCHOTICS | CLINICAL NEUROLOGY | PHARMACOLOGY & PHARMACY | DYSFUNCTION | EXTENDED-RELEASE | REMISSION | Humans | White Matter - drug effects | Corpus Callosum - drug effects | Male | Nerve Net - drug effects | Internal Capsule - drug effects | Paliperidone Palmitate - therapeutic use | Superior Sagittal Sinus - drug effects | Anisotropy | Delayed-Action Preparations - therapeutic use | Adult | Female | Schizophrenia - drug therapy | External Capsule - drug effects | Neuroimaging | Care and treatment | Usage
Journal Article
The Breast Journal, ISSN 1075-122X, 05/2019, Volume 25, Issue 3, pp. 510 - 511
Journal Article
Connecticut Medicine, ISSN 0010-6178, 09/2016, Volume 80, Issue 8, pp. 487 - 489
Tamoxifen is a selective estrogen- receptor modulator commonly associated with an increased risk of thrombotic events, including cere- bral venous thrombosis....
Tamoxifen | Superior sagittal sinus thrombosis | Thrombosis | Anticoagulants - administration & dosage | Antineoplastic Agents, Hormonal - administration & dosage | Humans | Middle Aged | Sagittal Sinus Thrombosis - etiology | Anticonvulsants - administration & dosage | Phlebography - methods | Treatment Outcome | Breast Neoplasms - drug therapy | Tamoxifen - administration & dosage | Warfarin - administration & dosage | Sagittal Sinus Thrombosis - diagnosis | Antineoplastic Agents, Hormonal - adverse effects | Blood Coagulation - drug effects | Sagittal Sinus Thrombosis - physiopathology | Piracetam - analogs & derivatives | Superior Sagittal Sinus - pathology | Blood Coagulation Tests - methods | Female | Magnetic Resonance Angiography - methods | Piracetam - administration & dosage | Superior Sagittal Sinus - diagnostic imaging | Tamoxifen - adverse effects | Sagittal Sinus Thrombosis - drug therapy
Tamoxifen | Superior sagittal sinus thrombosis | Thrombosis | Anticoagulants - administration & dosage | Antineoplastic Agents, Hormonal - administration & dosage | Humans | Middle Aged | Sagittal Sinus Thrombosis - etiology | Anticonvulsants - administration & dosage | Phlebography - methods | Treatment Outcome | Breast Neoplasms - drug therapy | Tamoxifen - administration & dosage | Warfarin - administration & dosage | Sagittal Sinus Thrombosis - diagnosis | Antineoplastic Agents, Hormonal - adverse effects | Blood Coagulation - drug effects | Sagittal Sinus Thrombosis - physiopathology | Piracetam - analogs & derivatives | Superior Sagittal Sinus - pathology | Blood Coagulation Tests - methods | Female | Magnetic Resonance Angiography - methods | Piracetam - administration & dosage | Superior Sagittal Sinus - diagnostic imaging | Tamoxifen - adverse effects | Sagittal Sinus Thrombosis - drug therapy
Journal Article
Medicine, ISSN 0025-7974, 08/2018, Volume 97, Issue 31, p. e11642
Rationale: Cerebral venous sinus thrombosis (CVST) is a complex life-threatening condition, and its etiology is not well understood. Although oral cyclosporin...
BREAST-CANCER | SUPERIOR SAGITTAL SINUS | MEDICINE, GENERAL & INTERNAL | RISK-FACTOR | OLD | cyclosporin A | cerebral venous sinus thrombosis | PATIENT | headache | TAMOXIFEN TREATMENT | ANEMIA | Cyclosporine - adverse effects | Humans | Anemia, Aplastic - drug therapy | Adult | Female | Immunosuppressive Agents - adverse effects | Sinus Thrombosis, Intracranial - chemically induced | Case studies | Care and treatment | Venous thrombosis | Diagnosis | Brain diseases
BREAST-CANCER | SUPERIOR SAGITTAL SINUS | MEDICINE, GENERAL & INTERNAL | RISK-FACTOR | OLD | cyclosporin A | cerebral venous sinus thrombosis | PATIENT | headache | TAMOXIFEN TREATMENT | ANEMIA | Cyclosporine - adverse effects | Humans | Anemia, Aplastic - drug therapy | Adult | Female | Immunosuppressive Agents - adverse effects | Sinus Thrombosis, Intracranial - chemically induced | Case studies | Care and treatment | Venous thrombosis | Diagnosis | Brain diseases
Journal Article
Journal of Neurosurgery: Pediatrics, ISSN 1933-0707, 10/2016, Volume 18, Issue 4, pp. 487 - 492
Profuse bleeding originating from an injured cerebral sinus can be a harrowing experience for any surgeon, particularly during an operation on a young child....
Superior sagittal sinus | Injury | Cerebral sinus | Hemispherotomy | Technique | Repair | Hemorrhage | SURGERY | repair | hemispherotomy | CATASTROPHIC EPILEPSY | REFRACTORY EPILEPSY | MANAGEMENT | RECONSTRUCTION | HEMISPHERECTOMY | technique | CLINICAL NEUROLOGY | CHILDREN | cerebral sinus | COLLAGEN SPONGE TACHOSIL | ANATOMY | superior sagittal sinus | PEDIATRICS | COMPLICATIONS | injury | hemorrhage | Blood Loss, Surgical - prevention & control | Device Removal | Intracranial Hemorrhages - diagnostic imaging | Absorbable Implants - adverse effects | Enterobacter cloacae | Humans | Enterobacteriaceae Infections - etiology | Infant | Male | Drug Resistant Epilepsy - diagnostic imaging | Enterobacteriaceae Infections - diagnostic imaging | Surgical Wound Infection - surgery | Surgical Wound Infection - etiology | Drug Resistant Epilepsy - complications | Hemispherectomy - adverse effects | Drug Resistant Epilepsy - surgery | Hemispherectomy - methods | Surgical Instruments - adverse effects | Enterobacteriaceae Infections - surgery | Superior Sagittal Sinus - diagnostic imaging | Superior Sagittal Sinus - injuries | Intracranial Hemorrhages - prevention & control | Surgical Wound Infection - diagnostic imaging
Superior sagittal sinus | Injury | Cerebral sinus | Hemispherotomy | Technique | Repair | Hemorrhage | SURGERY | repair | hemispherotomy | CATASTROPHIC EPILEPSY | REFRACTORY EPILEPSY | MANAGEMENT | RECONSTRUCTION | HEMISPHERECTOMY | technique | CLINICAL NEUROLOGY | CHILDREN | cerebral sinus | COLLAGEN SPONGE TACHOSIL | ANATOMY | superior sagittal sinus | PEDIATRICS | COMPLICATIONS | injury | hemorrhage | Blood Loss, Surgical - prevention & control | Device Removal | Intracranial Hemorrhages - diagnostic imaging | Absorbable Implants - adverse effects | Enterobacter cloacae | Humans | Enterobacteriaceae Infections - etiology | Infant | Male | Drug Resistant Epilepsy - diagnostic imaging | Enterobacteriaceae Infections - diagnostic imaging | Surgical Wound Infection - surgery | Surgical Wound Infection - etiology | Drug Resistant Epilepsy - complications | Hemispherectomy - adverse effects | Drug Resistant Epilepsy - surgery | Hemispherectomy - methods | Surgical Instruments - adverse effects | Enterobacteriaceae Infections - surgery | Superior Sagittal Sinus - diagnostic imaging | Superior Sagittal Sinus - injuries | Intracranial Hemorrhages - prevention & control | Surgical Wound Infection - diagnostic imaging
Journal Article
Brain Research, ISSN 0006-8993, 2010, Volume 1367, pp. 340 - 346
Abstract Fos expression in the brain was systematically investigated by means of immunohistochemical staining after electrical stimulation of the dura mater...
Neurology | FOS expression | Electrical stimulation | Headache | Rat | Morphological | ACTIVATION | PERIAQUEDUCTAL GRAY | IMMUNOREACTIVITY | C-FOS | NEUROSCIENCES | TRIGEMINAL NUCLEUS CAUDALIS | PAIN | CAT | NEURONS | RECEPTORS | Oncogene Proteins v-fos - metabolism | Brain - cytology | Electric Stimulation | Cell Count | Gene Expression Regulation - physiology | Rats | Male | Rats, Sprague-Dawley | Superior Sagittal Sinus - physiology | Serotonin Receptor Agonists - pharmacology | Brain - drug effects | Brain - metabolism | Gene Expression Regulation - drug effects | Triazoles - pharmacology | Superior Sagittal Sinus - anatomy & histology | Animals | Tryptamines - pharmacology | Statistics, Nonparametric | Wakefulness - physiology | Neurons - metabolism | Dura Mater - physiology | Neurons - drug effects | Immunohistochemistry | Brain
Neurology | FOS expression | Electrical stimulation | Headache | Rat | Morphological | ACTIVATION | PERIAQUEDUCTAL GRAY | IMMUNOREACTIVITY | C-FOS | NEUROSCIENCES | TRIGEMINAL NUCLEUS CAUDALIS | PAIN | CAT | NEURONS | RECEPTORS | Oncogene Proteins v-fos - metabolism | Brain - cytology | Electric Stimulation | Cell Count | Gene Expression Regulation - physiology | Rats | Male | Rats, Sprague-Dawley | Superior Sagittal Sinus - physiology | Serotonin Receptor Agonists - pharmacology | Brain - drug effects | Brain - metabolism | Gene Expression Regulation - drug effects | Triazoles - pharmacology | Superior Sagittal Sinus - anatomy & histology | Animals | Tryptamines - pharmacology | Statistics, Nonparametric | Wakefulness - physiology | Neurons - metabolism | Dura Mater - physiology | Neurons - drug effects | Immunohistochemistry | Brain
Journal Article
Brain Research, ISSN 0006-8993, 2010, Volume 1368, pp. 151 - 158
Abstract The trigeminovascular nociception induced by electrical stimulation of the dura mater surrounding the superior sagittal sinus in anesthetized animals...
Neurology | Stimulation frequency | Headache | Superior sagittal sinus | Behavior | Rat | TRIGEMINAL GANGLION | GENE-RELATED PEPTIDE | CLOSED CRANIAL WINDOW | FOS-LIKE IMMUNOREACTIVITY | BLOOD-FLOW | TRIGEMINOVASCULAR STIMULATION | NEUROSCIENCES | CERVICAL SPINAL-CORD | INFRAORBITAL NERVE | EVOKED-POTENTIALS | TAIL-FLICK | Dura Mater - physiopathology | Morphine - pharmacology | Grooming - drug effects | Rats | Male | Treatment Outcome | Rats, Sprague-Dawley | Serotonin Receptor Agonists - pharmacology | Triazoles - pharmacology | Animals | Tryptamines - pharmacology | Pain - drug therapy | Pain - physiopathology | Wakefulness | Narcotics - pharmacology | Electric Stimulation - methods | Superior Sagittal Sinus - physiopathology | Disease Models, Animal | Animal behavior | Morphine
Neurology | Stimulation frequency | Headache | Superior sagittal sinus | Behavior | Rat | TRIGEMINAL GANGLION | GENE-RELATED PEPTIDE | CLOSED CRANIAL WINDOW | FOS-LIKE IMMUNOREACTIVITY | BLOOD-FLOW | TRIGEMINOVASCULAR STIMULATION | NEUROSCIENCES | CERVICAL SPINAL-CORD | INFRAORBITAL NERVE | EVOKED-POTENTIALS | TAIL-FLICK | Dura Mater - physiopathology | Morphine - pharmacology | Grooming - drug effects | Rats | Male | Treatment Outcome | Rats, Sprague-Dawley | Serotonin Receptor Agonists - pharmacology | Triazoles - pharmacology | Animals | Tryptamines - pharmacology | Pain - drug therapy | Pain - physiopathology | Wakefulness | Narcotics - pharmacology | Electric Stimulation - methods | Superior Sagittal Sinus - physiopathology | Disease Models, Animal | Animal behavior | Morphine
Journal Article
Neuroscience Letters, ISSN 0304-3940, 01/2018, Volume 662, pp. 205 - 212
Cerebral venous sinus thrombosis (CVST) is a life-threatening disease with high misdiagnosis and mortality rates due to its complex etiology and unknown...
Cerebral venous sinus thrombosis | Pathophysiological change | Superior sagittal sinus rabbit | VEIN-THROMBOSIS | BLOOD-FLOW | NEUROSCIENCES | RAT MODEL | OCCLUSION | Rabbits | Thrombin - administration & dosage | Ferric Compounds - administration & dosage | Male | Sinus Thrombosis, Intracranial - physiopathology | Blood-Brain Barrier - drug effects | Sinus Thrombosis, Intracranial - chemically induced | Blood-Brain Barrier - metabolism | Brain - drug effects | Animals | Chlorides - administration & dosage | Brain - pathology | Disease Models, Animal | Sinus Thrombosis, Intracranial - pathology | Thrombin | Iron compounds | Thrombosis | Analysis | Blood clot
Cerebral venous sinus thrombosis | Pathophysiological change | Superior sagittal sinus rabbit | VEIN-THROMBOSIS | BLOOD-FLOW | NEUROSCIENCES | RAT MODEL | OCCLUSION | Rabbits | Thrombin - administration & dosage | Ferric Compounds - administration & dosage | Male | Sinus Thrombosis, Intracranial - physiopathology | Blood-Brain Barrier - drug effects | Sinus Thrombosis, Intracranial - chemically induced | Blood-Brain Barrier - metabolism | Brain - drug effects | Animals | Chlorides - administration & dosage | Brain - pathology | Disease Models, Animal | Sinus Thrombosis, Intracranial - pathology | Thrombin | Iron compounds | Thrombosis | Analysis | Blood clot
Journal Article
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, ISSN 0973-1482, 10/2013, Volume 9, Issue 4, pp. 751 - 753
Intracranial metastasis is a known complication of Burkitt's lymphoma, however, superior sagittal sinus invasion by dural metastasis from Burkitt's lymphoma is...
magnetic resonance imaging | superior sagittal sinus occlusion | ONCOLOGY | dural metastasis | Burkitt's lymphoma | Cytarabine - therapeutic use | Humans | Rituximab | Hydrocortisone - therapeutic use | Male | Methotrexate - therapeutic use | Cyclophosphamide - therapeutic use | Intracranial Pressure | Leukemic Infiltration - cerebrospinal fluid | Superior Sagittal Sinus - pathology | Adolescent | Vincristine - therapeutic use | Brain - pathology | Leukemic Infiltration - drug therapy | Intracranial Hypertension | Prednisolone - therapeutic use | Brain Neoplasms - radiotherapy | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Burkitt Lymphoma - drug therapy | Case studies | Complications and side effects | Care and treatment | Head and neck cancer | Metastasis | Diagnosis
magnetic resonance imaging | superior sagittal sinus occlusion | ONCOLOGY | dural metastasis | Burkitt's lymphoma | Cytarabine - therapeutic use | Humans | Rituximab | Hydrocortisone - therapeutic use | Male | Methotrexate - therapeutic use | Cyclophosphamide - therapeutic use | Intracranial Pressure | Leukemic Infiltration - cerebrospinal fluid | Superior Sagittal Sinus - pathology | Adolescent | Vincristine - therapeutic use | Brain - pathology | Leukemic Infiltration - drug therapy | Intracranial Hypertension | Prednisolone - therapeutic use | Brain Neoplasms - radiotherapy | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Burkitt Lymphoma - drug therapy | Case studies | Complications and side effects | Care and treatment | Head and neck cancer | Metastasis | Diagnosis
Journal Article
Cerebrovascular Diseases, ISSN 1015-9770, 2003, Volume 15, Issue 3, pp. 159 - 166
Background and Purpose: The use of thrombolytics is frequently mentioned in patients with cerebral venous or dural sinus thrombosis (CVDST) who deteriorate...
Systematic review | Venous thrombosis | Fibrinolysis | Thrombolysis | Dural sinus | THROMBECTOMY | RHEOLYTIC CATHETER | LOCAL INFUSION | systematic review | CLINICAL NEUROLOGY | fibrinolysis | dural sinus | SUPERIOR SAGITTAL SINUS | THERAPY | SIGMOID SINUS | ENDOVASCULAR TREATMENT | thrombolysis | PERIPHERAL VASCULAR DISEASE | SELECTIVE CATHETERIZATION | venous thrombosis | UROKINASE | Length of Stay | Hemorrhage - epidemiology | Humans | Tomography, X-Ray Computed | Treatment Outcome | Clinical Trials as Topic | Sinus Thrombosis, Intracranial - diagnosis | Fibrinolytic Agents - adverse effects | Magnetic Resonance Imaging | Fibrinolytic Agents - therapeutic use | Hemorrhage - chemically induced | Sinus Thrombosis, Intracranial - drug therapy | Sinus Thrombosis, Intracranial - complications
Systematic review | Venous thrombosis | Fibrinolysis | Thrombolysis | Dural sinus | THROMBECTOMY | RHEOLYTIC CATHETER | LOCAL INFUSION | systematic review | CLINICAL NEUROLOGY | fibrinolysis | dural sinus | SUPERIOR SAGITTAL SINUS | THERAPY | SIGMOID SINUS | ENDOVASCULAR TREATMENT | thrombolysis | PERIPHERAL VASCULAR DISEASE | SELECTIVE CATHETERIZATION | venous thrombosis | UROKINASE | Length of Stay | Hemorrhage - epidemiology | Humans | Tomography, X-Ray Computed | Treatment Outcome | Clinical Trials as Topic | Sinus Thrombosis, Intracranial - diagnosis | Fibrinolytic Agents - adverse effects | Magnetic Resonance Imaging | Fibrinolytic Agents - therapeutic use | Hemorrhage - chemically induced | Sinus Thrombosis, Intracranial - drug therapy | Sinus Thrombosis, Intracranial - complications
Journal Article
Transfusion, ISSN 0041-1132, 03/2015, Volume 55, Issue 3, pp. 571 - 575
Background Intravenous immunoglobulin (IVIG) is frequently given in autoimmune disorders. Side effects are usually mild but severe complications such as...
ARTERIAL | AUTOIMMUNE | CHRONIC IMMUNE THROMBOCYTOPENIA | THERAPY | VENOUS THROMBOEMBOLISM | PURPURA | DISEASE | POPULATION-BASED COHORT | RISK | CEREBRAL SINUS THROMBOSIS | HEMATOLOGY | Recurrence | Headache - etiology | Superior Sagittal Sinus | Humans | Meningitis, Aseptic - etiology | Middle Aged | Sagittal Sinus Thrombosis - etiology | Immunoglobulins, Intravenous - adverse effects | Blood Safety | Thrombophilia - epidemiology | Incidence | Thrombophilia - etiology | Purpura, Thrombocytopenic, Idiopathic - therapy | Female | Retrospective Studies | Contraceptives, Oral, Hormonal - adverse effects | Contraceptives, Oral, Hormonal - therapeutic use | Quebec - epidemiology | Menorrhagia - drug therapy | Menorrhagia - etiology | Sagittal Sinus Thrombosis - epidemiology | Adolescent | Autoimmune Diseases - therapy | Aged | Prednisone - therapeutic use | Vision Disorders - etiology | Pediatrics | Immunoglobulins | Thrombosis | Blood clot | Medical treatment
ARTERIAL | AUTOIMMUNE | CHRONIC IMMUNE THROMBOCYTOPENIA | THERAPY | VENOUS THROMBOEMBOLISM | PURPURA | DISEASE | POPULATION-BASED COHORT | RISK | CEREBRAL SINUS THROMBOSIS | HEMATOLOGY | Recurrence | Headache - etiology | Superior Sagittal Sinus | Humans | Meningitis, Aseptic - etiology | Middle Aged | Sagittal Sinus Thrombosis - etiology | Immunoglobulins, Intravenous - adverse effects | Blood Safety | Thrombophilia - epidemiology | Incidence | Thrombophilia - etiology | Purpura, Thrombocytopenic, Idiopathic - therapy | Female | Retrospective Studies | Contraceptives, Oral, Hormonal - adverse effects | Contraceptives, Oral, Hormonal - therapeutic use | Quebec - epidemiology | Menorrhagia - drug therapy | Menorrhagia - etiology | Sagittal Sinus Thrombosis - epidemiology | Adolescent | Autoimmune Diseases - therapy | Aged | Prednisone - therapeutic use | Vision Disorders - etiology | Pediatrics | Immunoglobulins | Thrombosis | Blood clot | Medical treatment
Journal Article
Molecular Neurobiology, ISSN 0893-7648, 9/2017, Volume 54, Issue 7, pp. 5583 - 5589
Cerebral venous outflow may play a decisive role in acute ischemic stroke. Here, we assessed the relation of cerebral sinus vein characteristics with clinical...
Neurology | Neurosciences | Biomarker | Biomedicine | Computed tomography | Outcome | Neurobiology | Cerebral veins | Ischemic stroke | Densitometry | Cell Biology | ANGIOGRAPHY | CEREBRAL VENOUS DRAINAGE | NEUROSCIENCES | FLOW | Stroke - diagnostic imaging | Cerebrovascular Circulation - drug effects | Humans | Middle Aged | Male | Treatment Outcome | Stroke - drug therapy | Infarction, Middle Cerebral Artery - therapy | Stroke - pathology | Brain Ischemia - drug therapy | Brain Ischemia - pathology | Thrombolytic Therapy - methods | Aged, 80 and over | Female | Aged | Brain Ischemia - diagnostic imaging | Stroke (Disease) | Medical colleges | CT imaging | Ischemia | Bone densitometry | Stroke | Correlation | Superior sagittal sinus | Medical imaging | Angiography | Mortality | Clinical trials | Regression analysis | Patients | Density | Discharge | Hemispheric laterality | Drainage | Drainage systems | Sinuses | Sinus | Cerebral blood flow | Imaging | Outflow | Death | Circulation
Neurology | Neurosciences | Biomarker | Biomedicine | Computed tomography | Outcome | Neurobiology | Cerebral veins | Ischemic stroke | Densitometry | Cell Biology | ANGIOGRAPHY | CEREBRAL VENOUS DRAINAGE | NEUROSCIENCES | FLOW | Stroke - diagnostic imaging | Cerebrovascular Circulation - drug effects | Humans | Middle Aged | Male | Treatment Outcome | Stroke - drug therapy | Infarction, Middle Cerebral Artery - therapy | Stroke - pathology | Brain Ischemia - drug therapy | Brain Ischemia - pathology | Thrombolytic Therapy - methods | Aged, 80 and over | Female | Aged | Brain Ischemia - diagnostic imaging | Stroke (Disease) | Medical colleges | CT imaging | Ischemia | Bone densitometry | Stroke | Correlation | Superior sagittal sinus | Medical imaging | Angiography | Mortality | Clinical trials | Regression analysis | Patients | Density | Discharge | Hemispheric laterality | Drainage | Drainage systems | Sinuses | Sinus | Cerebral blood flow | Imaging | Outflow | Death | Circulation
Journal Article